Par Pharmaceutical Investor Sues To Halt $1.9B TPG Deal

Law360, Wilmington (July 25, 2012, 8:20 PM EDT) -- A Par Pharmaceutical Cos. Inc. shareholder launched a class action in Delaware court on Tuesday challenging private equity firm TPG Capital's $1.9 billion bid to take the generic-drug maker private, calling the offer inadequate and opportunistic.

Rena Nadoff alleged in a Delaware Chancery Court complaint that the deal is the result of a flawed process favoring TPG and that it comes at a time when Par Pharmaceuticals’ rosy future prospects are not reflected in its stock price.

The shareholder pointed to the company’s February acquisition of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.